AU Patent

AU2012256237B2 — Pyrrolidinyl urea and pyrrolidinyl thiourea compounds as TrkA kinase inhibitors

Assigned to Array Biopharma Inc · Expires 2017-01-05 · 9y expired

What this patent protects

Compounds of Formula I: or stereoisomers, tautomers, or pharmaceutically acceptable salts, or solvates or prodrugs thereof, where R

USPTO Abstract

Compounds of Formula I: or stereoisomers, tautomers, or pharmaceutically acceptable salts, or solvates or prodrugs thereof, where R

Drugs covered by this patent

Patent Metadata

Patent number
AU2012256237B2
Jurisdiction
AU
Classification
—
Expires
2017-01-05
Drug substance claim
No
Drug product claim
No
Assignee
Array Biopharma Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.